IRCT20200105046010N114招募中Unknown
In-vivo Bioequivalence Study of ASA 80 mg EC Tablet of The Test Drug (Sajjad Darou, Iran) in Compared with The Reference Drug (ASPIRIN® 80 mg. EC Tablet. BUYER, Germany) In Iranian Healthy Volunteers
Sajad darou shargh0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28) kg/m^2
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to ASPIRI
研究者
相似试验
招募中
Unknown
In vivo Bioequivalence study of Aspirin tabletIRCT20220211053992N20Tabriz University of Medical Sciences24
招募中
不适用
In vivo Bioequivalence study of Aspirin tabletIRCT20220211053992N6Tabriz University of Medical Sciences24
已完成
不适用
Comparative in vivo evaluation of 2 Aspirin 81 mg Enteric-coated Tablet formulations.IRCT20180620040164N33Actover Pharmaceutical Co.24
招募中
不适用
Aspirin tablets 81mg (ASPIRIN® 81mg) Kharazmi , In- Vivo Bioequivalence in Iranian healthy volunteers.IRCT20200105046010N10Tabriz University of Medical Sciences24
招募中
Unknown
Investigating bioequivalence of valsartan tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N15Tabriz University of Medical Sciences24